Evaluating the management of intermittent claudication before and after publication of the Society of Vascular Surgery's Appropriate Use Criteria
Journal of Vascular Surgery · 2025-08 · 82 (2) · 526-533.e3
DOI: 10.1016/j.jvs.2024.12.133 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2025-08. Verfasst von Andrea Alonso und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, Boston Medical Center, Boston University Chobanian and Avedisian School of Medi…. Hauptthemen laut MEDLINE: Intermittent Claudication, Peripheral Arterial Disease, Vascular Surgical Procedures, Practice Patterns, Physicians'. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: AHRQ HHS, Cook Medical, Agency for Healthcare Research and Quality.
Abstract (Originalsprache)
OBJECTIVE: In April 2022, the Society for Vascular Surgery (SVS) published the Appropriate Use Criteria (AUC) for the management of intermittent claudication (IC). Our goal was to compare practice patterns before and after publication of the AUC to identify changes. METHODS: The Vascular Quality Initiative (VQI) peripheral vascular intervention (PVI) and suprainguinal and infrainguinal bypass registries were analyzed for interventions for IC. Relevant patient and intervention characteristics pre-AUC (2018-2019) and post-AUC (May 2022-December 2023) were compared. Key points of the AUC that are analyzable from the VQI include claudication severity, use of optimal medical therapy (OMT), smoking status, high-risk comorbid conditions (as indicators of operative risk), operative management of complex aortoiliac and femoropopliteal disease (TASC II C/D), common femoral artery (CFA) PVIs, and infrapopliteal procedures. RESULTS: There were 15,892 PVI, 2352 suprainguinal bypass, and 3480 infrainguinal bypass procedures analyzed. Changes consistent with the appropriateness ratings for PVI included more interventions for severe symptoms (72% vs 66.6%; P < .001), improvement in postoperative OMT (83% vs 79.7%; P < .001), fewer patients on dialysis undergoing PVI (2% vs 2.7%; P < .002), and less interventions on complex (TASC II C/D) aortoiliac (6.3% vs 9.5%; P < .001) and femoropopliteal (4.5% vs 5.8%; P < .001) anatomy. No changes were seen in the rates of preoperative smoking and preoperative OMT use, interventions on octogenarians, or in the use of extra-anatomic suprainguinal bypass, infrapopliteal bypass, or prosthetic conduit. Inconsistent with appropriateness ratings were more patients with congestive heart failure (15.1% vs 12.8%; P < .001) undergoing PVIs, and more PVIs for CFA (5.2% vs 3.4%; P < .001) and isolated infrapopliteal disease (5.7% vs 3.5%; P < .001). CONCLUSIONS: Since the publication of the AUC, there have been improvements with better OMT on discharge, fewer patients with end-stage renal disease undergoing interventions, and less endovascular treatment of complex disease. However, further work is needed to improve preoperative medical optimization in patients with IC undergoing an invasive intervention and decrease the use of endovascular interventions for CFA and infrapopliteal disease, extra-anatomic aortoiliac revascularizations, and prosthetic conduit use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, Department of Surgery, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA.
- Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins University School of Medicine, Baltimore, MD.
- Division of Vascular and Endovascular Surgery, University of California San Diego, La Jolla, CA.
- Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Medical Center, New York, NY.
- Division of Vascular and Endovascular Surgery, University of Michigan, Ann Arbor, MI.
- Division of Vascular and Endovascular Surgery, University of Massachusetts Chan Medical School, Worcester, MA.
Förderung
- AHRQ HHS
- Cook Medical
- Agency for Healthcare Research and Quality
Zitieren
APA
Alonso, A., Kobzeva-Herzog, A., Dalton-Petillo, S., Haqqani, M., Farber, A., King, E. G., Hicks, C. W., Malas, M., Garg, K., Osborne, N., Simons, J. P., & Siracuse, J. J. (2025). Evaluating the management of intermittent claudication before and after publication of the Society of Vascular Surgery's Appropriate Use Criteria. Journal of Vascular Surgery, 82(2), 526-533.e3. https://doi.org/10.1016/j.jvs.2024.12.133
Vancouver
Alonso A, Kobzeva-Herzog A, Dalton-Petillo S, Haqqani M, Farber A, King EG, et al. Evaluating the management of intermittent claudication before and after publication of the Society of Vascular Surgery's Appropriate Use Criteria. Journal of Vascular Surgery. 2025;82(2):526-533.e3. doi:10.1016/j.jvs.2024.12.133
BibTeX
@article{Alonso2025,
author = {Alonso, Andrea and Kobzeva-Herzog, Anna and Dalton-Petillo, Stephen and Haqqani, Maha and Farber, Alik and King, Elizabeth G and Hicks, Cailtin W and Malas, Mahmoud and Garg, Karan and Osborne, Nicholas and Simons, Jessica P and Siracuse, Jeffrey J},
title = {Evaluating the management of intermittent claudication before and after publication of the Society of Vascular Surgery's Appropriate Use Criteria},
journal = {Journal of Vascular Surgery},
year = {2025},
volume = {82},
number = {2},
pages = {526--533.e3},
doi = {10.1016/j.jvs.2024.12.133}
}
EUVIMED